Phylo launches Target Atlas for drug target prioritization with Parkinson’s edition
Phylo released Target Atlas on September 29, 2026, an AI-powered tool built on its Biomni Lab platform. The application speeds up target prioritization in drug development by reducing evidence-gathering from months to days. It uses AI agents to synthesize fragmented data from genetics, clinical activity, safety, and literature, while scientists retain control over weighting evidence and…
Key points
- Phylo’s Target Atlas cuts drug target prioritization from months to days using AI agents and expert-weighted evidence
- Parkinson’s edition launched with The Michael J. Fox Foundation’s T2T initiative, covering 21 nominated targets from 290 evaluated
- Enterprise version supports 20,000+ targets per disease with proprietary data integration, priced via annual license
Phylo’s enterprise edition supports 20,000+ targets per disease, proprietary data integration, and AI/ML scoring. The company plans to expand the public edition across diseases and seeks partnerships with foundations or consortia to sponsor additional free editions. Phylo, based in South San Francisco, raised a $13.5 million seed round co-led by Andreessen Horowitz and Menlo Ventures’ Anthology Fund, with backing from Anthropic. The tool is available at biomni.phylo.bio.
Phylo’s Target Atlas Puts AI Agents on Drug Target Prioritization
Unite.AI · 29 September 2026
Loading the full article…
This text was published by Unite.AI. It is reproduced here with attribution so you can read it in full; the rights remain with the publisher. Read it at the source ↗
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Enterprise & Industry
All →- AWS details AI contract intelligence platform using Bedrock AgentCore · 1 src
- Slack adds AI features to Salesforce integration at Dreamforce · 1 src
- ExodusPoint integrates Anthropic’s Claude into its Atlas AI platform for hedge fund workflows · 1 src
- OpenAI delays GPT-6.1 Astra launch after safety concerns raised by researchers · 3 src
- Condé Nast cuts video search time from 250 minutes to 2 minutes using Amazon Bedrock and TwelveLabs Marengo · 1 src
Comments
via GitHub Discussions